• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体内注射后中毒性眼内炎爆发。

Toxic vitreitis outbreak after intravitreal injection.

机构信息

University Hospital Freiburg, Eye Hospital, Freiburg, Germany.

出版信息

Retina. 2010 Feb;30(2):332-8. doi: 10.1097/iae.0b013e3181baf691.

DOI:10.1097/iae.0b013e3181baf691
PMID:20175274
Abstract

PURPOSE

To report clinical and epidemiologic findings of 11 patients with severe intraocular inflammation after intravitreal injection.

METHODS

This is a single-center, retrospective, interventional case series of 11 patients with severe intraocular inflammation after intravitreal injection at 1 referral center. The clinical data of all patients (3,357) who underwent intravitreal injection between February 2007 and February 2008 were analyzed. All incidents of postoperative intraocular inflammatory reaction were documented.

RESULTS

During the examination period, we identified 11 cases of intraocular inflammation after intravitreal injection. Only one thereof was infectious endophthalmitis with retinal abscess. All others were toxic vitreitis. Seven eyes exhibited hypopyon and five disseminated retinal hemorrhages. The toxic reaction occurred within 48 hours after injection, whereas in the endophthalmitis case, it occurred after 72 hours. We believe that the cause of this reaction was the particular syringe brand used. After changing to another syringe brand, no further cases of toxic vitreitis occurred during the next 6 months.

CONCLUSION

Toxic inflammatory reaction is not only a complication of cataract surgery, but may also occur after intravitreal injection. A critical review of all processes involved and materials used would help to prevent further cases of toxic vitreitis.

摘要

目的

报告 11 例玻璃体内注射后严重眼内炎症的临床和流行病学发现。

方法

这是一家转诊中心的 11 例玻璃体内注射后严重眼内炎症的单中心、回顾性、干预性病例系列研究。分析了 2007 年 2 月至 2008 年 2 月期间所有接受玻璃体内注射的 3357 例患者的临床资料。所有术后眼内炎症反应的事件均有记录。

结果

在检查期间,我们发现了 11 例玻璃体内注射后的眼内炎症。只有 1 例是视网膜脓肿感染性眼内炎,其余均为中毒性玻璃体炎。7 只眼有前房积脓,5 只眼有弥漫性视网膜出血。中毒反应发生在注射后 48 小时内,而眼内炎病例则发生在 72 小时后。我们认为这种反应的原因是使用了特定的注射器品牌。更换另一种注射器品牌后,在接下来的 6 个月内,没有再发生中毒性玻璃体炎。

结论

毒性炎症反应不仅是白内障手术的并发症,也可能发生在玻璃体内注射后。对所有涉及的过程和使用的材料进行严格审查有助于防止进一步发生毒性玻璃体炎。

相似文献

1
Toxic vitreitis outbreak after intravitreal injection.玻璃体内注射后中毒性眼内炎爆发。
Retina. 2010 Feb;30(2):332-8. doi: 10.1097/iae.0b013e3181baf691.
2
[Complications of intravitreal injections--own experience].[玻璃体内注射的并发症——自身经验]
Klin Oczna. 2011;113(4-6):127-31.
3
Toxic vitreitis outbreak after intravitreal injection.玻璃体内注射后发生毒性玻璃体炎疫情。
Retina. 2011 Mar;31(3):631; author reply 631. doi: 10.1097/IAE.0b013e31820bde95.
4
Bilateral simultaneous intravitreal injections in the office setting.在诊室环境下进行双眼同时玻璃体腔内注射。
Am J Ophthalmol. 2009 Jul;148(1):66-9.e1. doi: 10.1016/j.ajo.2009.02.013. Epub 2009 Apr 29.
5
Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.玻璃体内注射曲安奈德治疗眼内水肿和新生血管性疾病。
Acta Ophthalmol Scand. 2005 Dec;83(6):645-63. doi: 10.1111/j.1600-0420.2005.00592.x.
6
[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].玻璃体内注射曲安奈德治疗眼内水肿和新生血管性疾病
Ophthalmologe. 2004 Feb;101(2):113-20. doi: 10.1007/s00347-003-0982-0.
7
An outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinolone.眼内注射复方贝伐单抗和曲安奈德后真菌性眼内炎爆发。
JAMA Ophthalmol. 2013 Jul;131(7):864-9. doi: 10.1001/jamaophthalmol.2013.88.
8
Intravitreal silicone oil droplets after intravitreal drug injections.玻璃体内注射药物后出现的玻璃体内硅油滴。
Retina. 2008 Jul-Aug;28(7):996-1001. doi: 10.1097/IAE.0b013e31816c6868.
9
Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.曲安奈德玻璃体腔内注射与贝伐单抗治疗视网膜分支静脉阻塞继发黄斑水肿的疗效比较。
Eye (Lond). 2009 Nov;23(11):2023-33. doi: 10.1038/eye.2009.230. Epub 2009 Oct 2.
10
Histopathology of streptococcus mitis/oralis endophthalmitis after intravitreal injection with bevacizumab: a report of 7 patients.玻璃体腔内注射贝伐单抗后口腔链球菌/咽峡链球菌性眼内炎的组织病理学:7 例报告。
Ophthalmology. 2014 Mar;121(3):702-8. doi: 10.1016/j.ophtha.2013.10.015. Epub 2014 Jan 16.

引用本文的文献

1
Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics (ReST) Committee.玻璃体内注射培西加可兰后的视网膜血管炎:来自美国视网膜专家协会治疗研究与安全(ReST)委员会的报告
J Vitreoretin Dis. 2023 Dec 21;8(1):9-20. doi: 10.1177/24741264231220224. eCollection 2024 Jan-Feb.
2
Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results.修改阿柏西普制造工艺对新生血管性年龄相关性黄斑变性患者的影响:MAPLE研究结果
Clin Ophthalmol. 2023 May 11;17:1367-1384. doi: 10.2147/OPTH.S405994. eCollection 2023.
3
Ocular inflammation after agitation of siliconized and silicone oil-free syringes: a randomized, double-blind, controlled clinical trial.
无硅油硅化注射器搅动后的眼部炎症:一项随机、双盲、对照临床试验。
Int J Retina Vitreous. 2022 Jun 17;8(1):41. doi: 10.1186/s40942-022-00387-z.
4
Toxic Intraocular Syndrome.毒性眼内综合征
J Ophthalmic Vis Res. 2022 Jan 21;17(1):155-156. doi: 10.18502/jovr.v17i1.10184. eCollection 2022 Jan-Mar.
5
Manifestations of intraocular inflammation over time in patients on brolucizumab for neovascular AMD.接受 brolucizumab 治疗新生血管性 AMD 患者眼内炎症随时间的表现。
Graefes Arch Clin Exp Ophthalmol. 2022 Jun;260(6):1843-1856. doi: 10.1007/s00417-021-05518-0. Epub 2021 Dec 21.
6
Brolucizumab-associated intraocular inflammation in eyes without retinal vasculitis.在无视网膜血管炎的眼中与布罗鲁单抗相关的眼内炎症。
J Vitreoretin Dis. 2021 Jul;5(4):326-332. doi: 10.1177/2474126420975303. Epub 2020 Dec 15.
7
Non-infectious Intraocular Inflammation Following Intravitreal Anti-Vascular Endothelial Growth Factor Injection.玻璃体内注射抗血管内皮生长因子后发生非感染性眼内炎症。
Turk J Ophthalmol. 2021 Feb 25;51(1):32-37. doi: 10.4274/tjo.galenos.2020.84042.
8
Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab.玻璃体内注射布罗珠单抗后发生的视网膜血管阻塞性血管炎
J Vitreoretin Dis. 2020 Jul;4(4):269-279. doi: 10.1177/2474126420930863. Epub 2020 Jul 1.
9
Assessment of bevacizumab quality and stability in repackaged syringes for clinical use.临床使用的重新包装注射器中贝伐单抗质量与稳定性的评估。
Eur J Hosp Pharm. 2016 Nov;23(6):343-347. doi: 10.1136/ejhpharm-2015-000853. Epub 2016 Mar 21.
10
[Endophthalmitis].[眼内炎]
Ophthalmologe. 2018 Aug;115(8):697-706. doi: 10.1007/s00347-018-0729-6.